Popular on EntSun
- Female Motorsports Sponsorship & Expansion; Acquisition Agreement of UAE-Based Sports Incubator by Online Lottery & Sports Game Provider: Lottery.com - 233
- Experience Trembling Firsthand with the New AgeMan® Tremor Simulator - 216
- WOA Entertainment Group Unveils Independent No.1's: Breakthrough Artists II —A Celebration of Indie Excellence - 213
- Edtech Startup Young Commanders Launches 'Visionaries Without Sight' Collection Celebrating Blind and Visually Impaired Historical Figures - 208
- IRF Builders Forum Brings Global Leaders to Washington, D.C. to Advance Religious Freedom Through Cooperative Engagement - 173
- Let's Talk Series: At the Crossroads: Immigration Today - 155
- Token-Operated Sake Service Opens at Tobu Nikko Station - 126
- JMC Princess Announces Release of Empowering New Single "PRETTY" – A Summer Anthem for Young Girls Everywhere - 123
- Honoring Black History, Culture, and Community in Fall River - 122
- $77.8 Million in Revenue Through April 2025, Confirms Full-Year Guidance; Fast-Track to 400 Million Run Rate; $1 Billion Target After Key Acquisition - 116
Stomach Cancer/Gastric Cancer Treatment Market Depth Analysis By Statistics, Industry Size Report
EntSun News/10833274
The global stomach cancer treatment market size is expected to reach USD 8.20 billion by 2026, exhibiting a CAGR of 15.3% during the forecast period. One of the major forces behind the rise of this market is the increasing prevalence of cancer in general and stomach cancer in particular worldwide. The GLOBOCAN 2018, which is a report on the global burden of cancer produced by the International Agency for Research on Cancer (IARC), estimates that in 2018, new cancer cases will be around 18 million and cancer-related deaths will be close to 9.6 million. Further, stomach cancer will account for 8.2% of the new cancer cases. Statistics released by the World Cancer Research Fund (WCRF) substantiate the IARC's findings. According to the WCRF, gastric cancer is the fourth mostly commonly diagnosed cancer worldwide, with 1 million new reported cases. As the incidence of stomach cancer increases across the globe, the demand for stomach cancer drugs will rise commensurately, spelling good news for this market.
An Overview of the Impact of COVID-19 on this Market:
The emergence of COVID-19 has brought the world to a standstill. We understand that this health crisis has brought an unprecedented impact on businesses across industries. However, this too shall pass. Rising support from governments and several companies can help in the fight against this highly contagious disease. There are some industries that are struggling and some are thriving. Overall, almost every sector is anticipated to be impacted by the pandemic.
More on EntSun News
We are taking continuous efforts to help your business sustain and grow during COVID-19 pandemics. Based on our experience and expertise, we will offer you an impact analysis of corona virus outbreak across industries to help you prepare for the future.
Click here to get the short-term and long-term impact of COVID-19 on this [Market].
For More Information : https://www.fortunebusinessinsights.com/stomach-gastric-cancer-treatment-market-102094
Fortune Business Insights™ shares the above information in its new report, titled "Stomach Cancer/Gastric Cancer Treatment Market Size, Share & Industry Analysis, By Drug Type (Programmed Cell Death Protein 1 (PD-1) Inhibitors, Human Epidermal Growth Factor Receptor (HER2) Antagonists, Vascular Endothelial Growth Factor Receptor (VEGFR) Antagonists, and Others), By Disease Indication (Gastric Adenocarcinoma, Gastrointestinal Stromal Tumor (GIST), and Gastric Neuroendocrine Tumors (gNET)), By Route of Administration (Oral and Parenteral) By Distribution Channel (Hospital Pharmacy, Retail Pharmacy, and Online Pharmacy) and Regional Forecast, 2019-2026". According to the report, the market value stood at USD 2.61 billion in 2018. The other highlights of the report include:
Encouraging Pipeline Candidates to Create Investment Opportunities
More on EntSun News
Potential pipeline candidates are being researched and developed as targeted therapies to treat gastric cancers. Targeted therapies involve specialized drugs that halt the spread of cancer by intervening or targeting specific molecules. For instance, Pfizer and EMD Serono Inc., is currently engaged in developing a drug called Avelumab for the treatment of advanced gastric cancer. Similarly, OncoQR ML recently declared that it has attained proof-of-concept (PoC) for its leading oncology product for gastrointestinal cancer called OQR100 (G17/little gastrin). Such research undertakings are emerging as one of the defining stomach cancer treatment market trends as these projects are encouraging players to focus their investment energies on enhancing their R&D capacities.
An Overview of the Impact of COVID-19 on this Market:
The emergence of COVID-19 has brought the world to a standstill. We understand that this health crisis has brought an unprecedented impact on businesses across industries. However, this too shall pass. Rising support from governments and several companies can help in the fight against this highly contagious disease. There are some industries that are struggling and some are thriving. Overall, almost every sector is anticipated to be impacted by the pandemic.
More on EntSun News
- Couture By Elesia Reclaims The Runway Of Everyday Life With Bold Return And New Hiya Sunshine Line
- BillBoards Inc. Hits the Road with God Bless America Tour and Reality Series Now Streaming on Tubi TV
- Cynthia Pinot Among Artists Selected for Renowned London Art Biennale 2025
- Real Estate Experts Highlight Jersey Shore as a Smart Buy in 2025
- Slipaway Food Truck Park & Marina announces opening weekend July 4-6
We are taking continuous efforts to help your business sustain and grow during COVID-19 pandemics. Based on our experience and expertise, we will offer you an impact analysis of corona virus outbreak across industries to help you prepare for the future.
Click here to get the short-term and long-term impact of COVID-19 on this [Market].
For More Information : https://www.fortunebusinessinsights.com/stomach-gastric-cancer-treatment-market-102094
Fortune Business Insights™ shares the above information in its new report, titled "Stomach Cancer/Gastric Cancer Treatment Market Size, Share & Industry Analysis, By Drug Type (Programmed Cell Death Protein 1 (PD-1) Inhibitors, Human Epidermal Growth Factor Receptor (HER2) Antagonists, Vascular Endothelial Growth Factor Receptor (VEGFR) Antagonists, and Others), By Disease Indication (Gastric Adenocarcinoma, Gastrointestinal Stromal Tumor (GIST), and Gastric Neuroendocrine Tumors (gNET)), By Route of Administration (Oral and Parenteral) By Distribution Channel (Hospital Pharmacy, Retail Pharmacy, and Online Pharmacy) and Regional Forecast, 2019-2026". According to the report, the market value stood at USD 2.61 billion in 2018. The other highlights of the report include:
- Elaborative overview of the industry outlook;
- 360-degree analysis of the factors driving and restraining the market;
- Careful study of the different market segments; and
- Detailed research into the regional and competitive dynamics influencing the market growth.
Encouraging Pipeline Candidates to Create Investment Opportunities
More on EntSun News
- 16-Year-Old Entrepreneur Discovers All-Natural Skincare Breakthrough That Works in Just 48 Hours
- Collision Course Concert Series Returns to Atlanta
- $18 Price Target Issued in New Research Report After $34 Million Revenue Forecast from Acquisition; $101.5 Million Net Revenue in 2025; NAS DAQ: IQST
- West Dentistry Welcomes New Oral Surgeon to Enhance Patient Care
- BayView Entertainment, Inc. Releases Multi Award-Winning Horror Film 'The Forest Through the Trees'
Potential pipeline candidates are being researched and developed as targeted therapies to treat gastric cancers. Targeted therapies involve specialized drugs that halt the spread of cancer by intervening or targeting specific molecules. For instance, Pfizer and EMD Serono Inc., is currently engaged in developing a drug called Avelumab for the treatment of advanced gastric cancer. Similarly, OncoQR ML recently declared that it has attained proof-of-concept (PoC) for its leading oncology product for gastrointestinal cancer called OQR100 (G17/little gastrin). Such research undertakings are emerging as one of the defining stomach cancer treatment market trends as these projects are encouraging players to focus their investment energies on enhancing their R&D capacities.
0 Comments
Latest on EntSun News
- Construcción del Corredor Norte–Sur (NSC) de Singapur
- New Report: Slip and Fall Accidents Rank as the Leading Cause of Construction Site Fatalities
- Get Your Cowboy Boots On! Causeway Country BBQ Music Festival Kicks Off September 12–14 in Ft. Pierce
- Retired Hobbyist Launches Bold Weekly Album Project Using AI Songwriting Tools
- DimHum Launches Revolutionary CrowdShipping Service
- Eolian Signs New Information Exchange Agreement with the U.S. Department of Defense for Technology Innovation
- Jekale (JK) Debuts R-B Single "Jungle" Inspired by Fashion, Storytelling, and Self-Discovery
- Favorite Wedding Décor Ideas to Inspire Your Big Day: From Vision to Venue
- Infinite Health Introduces Cutting-Edge Regenerative Medicine for Wound Care with Trip Goolsby, MD
- Riser Music's LYKN Adds India, Mexico & U.s. Dates To "unleashed" World Tour
- A Theatrical Experience Like No Other: "A Praying Mama, A Rebellious Son" Comes August 30
- Prolific Hollywood Actor Phillip E. Walker-MFA is Experiencing His Best Year of Employment Ever
- Top Dentist Concord CA, Smile Makers Dental Care, Celebrates 500 5-Star Reviews
- Bio-Inspired Technology-Dynamic and Adaptable for unknown real-world environments
- ALIVE and KICKING: LAUGHTER NEVER GETS OLD has its World Premiere July 11-20 in St. Charles, IL
- Michael Reafsnyder opens solo exhibition at Scott Richards Contemporary Art in San Francisco
- Valley Sleep Therapy Expands to Prescott with New Location at Crossings Road
- Live Courageously Hosts Ann-Marie Murrell, Author, Journalist, Former Political Commentator
- $17.4 Million Total Revenue for First Half of 2025 (up 31.8% YOY) for Global Wet Trades Services Provider with High Value Bitcoin Investments
- $12.8 Million Net Revenue for 2024 for Cloud-Based Crowdsourcing Recruitment and SaaS-Enabled HR Solutions Provider: Baiya International Group Inc